Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Middle Meningeal Artery Embolization for Chronic Subdural Hematomas (STORMM) — Stella

Home/Chronic Subdural Hematomas/

View on ClinicalTrials.gov

Recruiting

Back to Chronic Subdural Hematomas trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Switzerland

Geneva University Hospitals, Geneva

EOC, Lugano

Key details

Sponsor

University Hospital, Geneva

Enrollment target

~180 participants

Started

February 2025

Primary completion

January 2027

Age range

18 Years – 100 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.